Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04566328 |
|
Recruitment Status :
Recruiting
First Posted : September 28, 2020
Last Update Posted : June 23, 2023
|
Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Eastern Cooperative Oncology Group ( ECOG-ACRIN Cancer Research Group )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Plasma Cell Myeloma RISS Stage I Plasma Cell Myeloma RISS Stage II Plasma Cell Myeloma | Drug: Bortezomib Biological: Daratumumab and Hyaluronidase-fihj Drug: Dexamethasone Drug: Lenalidomide Other: Quality-of-Life Assessment | Phase 3 |
Show detailed description
Hide detailed description
PRIMARY OBJECTIVE:
I. To determine if bortezomib, daratumumab and hyaluronidase-fihj (daratumumab), lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab and lenalidomide (DR) maintenance after standard induction therapy with daratumumab, lenalidomide and dexamethasone (DRd) results in superior overall survival compared to DRd consolidation followed by DR maintenance, in minimal residual disease (MRD) positive patients.
SECONDARY OBJECTIVES:
I. To determine if Btz-DRd consolidation followed by DR maintenance after standard induction therapy with DRd results in superior overall survival compared to DRd consolidation followed by DR maintenance in MRD negative patients.
II. To determine if Btz-DRd consolidation followed by DR maintenance after standard induction therapy with DRd results in superior progression-free survival compared to DRd consolidation followed by DR maintenance in both MRD positive and MRD negative patients.
III. To describe and compare the incidence of toxicities during consolidation between Btz-DRd and DRd arms.
IV. To assess the improvement in MRD negative rate with consolidation among patients who are MRD positive after induction.
V. To assess the sustained MRD negative rate among patients who are MRD negative after induction.
PATIENT REPORTED OUTCOMES (PRO) OBJECTIVES:
I. To quantify the extent to which the addition of bortezomib to DRd over consolidation treatment contributes to neuropathy and associated physical and functional impairments. (Primary PRO Objective) II. To evaluate the rate of resolution of neurotoxicity and associated physical and functional impairments following completion of consolidation therapy. (Secondary PRO Objective) III. To investigate the relationship between MRD status and patient reported health-related quality of life outcomes. (Exploratory PRO Objective) IV. To evaluate attributes of select patient reported treatment-emergent symptomatic adverse events (PRO- Common Terminology Criteria for Adverse Events [CTCAE]) longitudinally and compare responses with provider-reported adverse events. (Exploratory PRO Objective) V. To tabulate PRO compliance and completion rates. (Exploratory PRO Objective)
IMAGING OBJECTIVES:
I. To evaluate the association between post-induction fludeoxyglucose F-18 (18F-FDG) positron emission tomography (PET)/computed tomography (CT) and patient outcomes (overall survival [OS] and progression-free survival [PFS]). (Primary Imaging Objective) II. To evaluate the association between baseline 18F-FDG PET/CT and patient outcomes (PFS and OS). (Secondary Imaging Objective) III. To compare overall survival with the addition of Bortezomib to consolidation DRd therapy among 18F-FDG PET/CT-positive and 18F-FDG PET/CT-negative subgroups. (Secondary Imaging Objective) IV. To evaluate the ability of baseline 18F-FDG PET/CT to predict post-induction depth of response as measured by MRD assessment. (Secondary Imaging Objective) V. To evaluate the ability of post-induction 18F-FDG PET/CT to predict MRD conversion post-consolidation. (Secondary Imaging Objective) VI. To utilize 18F-FDG PET/CT, standard risk factors and clinical data to identify distinct subgroups with differing patient outcomes (PFS and OS). (Exploratory Imaging Objective) VII. To compare the various qualitative 18F-FDG PET/CT criteria to determine which criteria yields superior risk stratification. (Exploratory Imaging Objective)
OUTLINE:
ARM A (INDUCTION): All patients receive standard induction therapy comprising the following: daratumumab subcutaneously (SC) on days 1, 8, 15, and 22 of cycles 1-2, days 1 and 15 of cycles 3-6, and day 1 of cycles 7-9, lenalidomide orally (PO) daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.
After completion of standard induction therapy, patients are randomized to 1 of 2 arms.
ARM B:
CONSOLIDATION: Patients receive bortezomib SC on days 1, 8, and 15, daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.
MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21 and daratumumab SC on day 1. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
ARM C:
CONSOLIDATION: Patients receive daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.
MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21, and daratumumab SC on day 1. Cycles repeats every 28 days in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months if less than 2 years from study entry, every 6 months if 2-5 years from study entry, then annually for up to 15 years from study entry.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 1450 participants |
| Allocation: | Randomized |
| Intervention Model: | Sequential Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation |
| Actual Study Start Date : | February 24, 2021 |
| Estimated Primary Completion Date : | December 31, 2027 |
| Estimated Study Completion Date : | December 31, 2027 |
Resource links provided by the National Library of Medicine
MedlinePlus Genetics related topics:
Multiple myeloma
MedlinePlus related topics:
Multiple Myeloma
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Arm A (daratumumab, lenalidomide, dexamethasone)
INDUCTION: All patients receive standard induction therapy comprising the following: daratumumab subcutaneously (SC) on days 1, 8, 15, and 22 of cycles 1-2, days 1 and 15 of cycles 3-6, and day 1 of cycles 7-9, lenalidomide orally (PO) daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.
|
Biological: Daratumumab and Hyaluronidase-fihj
Given SC
Other Names:
Drug: Dexamethasone Given PO
Other Names:
Drug: Lenalidomide Given PO
Other Names:
Other: Quality-of-Life Assessment Ancillary studies
Other Name: Quality of Life Assessment |
|
Experimental: Arm B (bortezomib, daratumumab, lenalidomide, dexamethasone)
CONSOLIDATION: Patients receive bortezomib SC on days 1, 8, and 15, daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21 and daratumumab SC on day 1. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. |
Drug: Bortezomib
Given SC
Other Names:
Biological: Daratumumab and Hyaluronidase-fihj Given SC
Other Names:
Drug: Dexamethasone Given PO
Other Names:
Drug: Lenalidomide Given PO
Other Names:
Other: Quality-of-Life Assessment Ancillary studies
Other Name: Quality of Life Assessment |
|
Active Comparator: Arm C (daratumumab, lenalidomide, dexamethasone)
CONSOLIDATION: Patients receive daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21, and daratumumab SC on day 1. Cycles repeats every 28 days in the absence of disease progression or unacceptable toxicity. |
Biological: Daratumumab and Hyaluronidase-fihj
Given SC
Other Names:
Drug: Dexamethasone Given PO
Other Names:
Drug: Lenalidomide Given PO
Other Names:
Other: Quality-of-Life Assessment Ancillary studies
Other Name: Quality of Life Assessment |
Primary Outcome Measures :
- Consolidation overall survival [ Time Frame: Time from Step 2 randomization at the start of consolidation to death or to the date last known alive, assessed up to 15 years ]Will be estimated using the Kaplan-Meier (KM) method and compared using a stratified log-rank test. Stratified cox proportional hazards regression will produce treatment hazard ratio (bortezomib, daratumumab and hyaluronidase-fihj (daratumumab), lenalidomide and dexamethasone [Btz-DRd] then daratumumab, lenalidomide and dexamethasone [DRd] then daratumumab and lenalidomide [DR]).
Secondary Outcome Measures :
- Consolidation progression-free survival [ Time Frame: Time from Step 2 randomization at the start of consolidation until the earlier of progression or death due to any cause, assessed up to 15 years ]Patients alive without disease progression will be censored at date of last disease evaluation. Only deaths that occur within 3 months of the last disease evaluation are considered events.
- Incidence of adverse events [ Time Frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance). ]
- Incidence of grade 3 or higher non-hematologic adverse events [ Time Frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance). ]
- Incidence of grade 3 or higher adverse events [ Time Frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance). ]
- Best response [ Time Frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance). ]
- FACT-Ntx TOI recovery rate (Patient reported outcome [PRO]) [ Time Frame: From end of induction through consolidation up to 1 year of maintenance, up to 21 weeks ]Defined as the proportion of patients with the FACT-Ntx TOI score returning to baseline level reached at consolidation randomization after experiencing a MID decrease while on up to 1 year of maintenance.
Other Outcome Measures:
- Change in Functional Assessment of Cancer Therapy - Neurotoxicity Trial Outcome Index (FACT-Ntx TOI) score (Patient reported outcome) [ Time Frame: From end of induction to after completion of 9 cycles of consolidation, a period of approximately 36 weeks (9 months) ]Calculated as the difference after completion of 9 cycles of consolidation therapy from end of induction. Scores can range from a minimum of 0 and a maximum of 44. A higher score on this assessment means a worse outcome.
- Levels and changes of FACT-General (G) (physical well-being [PWB] + functional well-being [FWB]) score (PRO) [ Time Frame: From the end of induction through 1 year of maintenance, 21 weeks ]The FACT-G is a single outcome measure made up of the PWB and FWB components. Scores range from a minimum of 0 and a maximum of 56. For this assessment, a higher score means a better outcome.
- Presence, frequency, interference, amount and/or severity of select PRO- Common Terminology Criteria for Adverse Events (CTCAEs) (PRO) [ Time Frame: Up to 15 years ]Presence, frequency, interference, amount and/or severity of select PRO-CTCAEs tabulated at each measurement.
- Comparison of selected PRO-CTCAEs with provider obtained assessment of same CTCAE items (PRO) [ Time Frame: Up to 15 years ]
- PRO compliance rate [ Time Frame: Up to 15 years ]Defined as the proportion of patients who submit the given PRO instrument among those eligible at each time point which excludes those missing by design (due to death or disease progression, early treatment discontinuation).
- PRO completion rate [ Time Frame: Up to 15 years ]Defined as the proportion of patients who complete given PRO instrument based on the instrument's scoring system among those eligible at each time point.
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- STEP 0 - Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2 (PS 3 allowed if secondary to pain)
- STEP 0 - Patient must have newly diagnosed multiple myeloma (MM) by International Myeloma Working Group (IMWG) criteria
- STEP 0 - Patient must agree to register to the mandatory REVLIMID Risk Evaluation and Mitigation Strategy (RevREMS) program and be willing and able to comply with the requirements of RevREMS
-
STEP 0 - Patient must be able to undergo diagnostic bone marrow aspirate following preregistration.
- NOTE: Bone marrow aspirate specimen must be submitted to Adaptive Biotechnologies for clonoSEQ Assay
- NOTE: Adaptive Biotechnologies will release results to the diagnostic Portal from the Clonality (ID) test within fourteen (14) days of receipt and reconciliation of fresh bone marrow specimen to the submitting institution
- STEP 1 - Patient must meet all eligibility criteria in STEP 0 with exception of allergy requirement
- STEP 1 - Institution must have received the Clonality (ID) test results from Adaptive Biotechnologies and dominant sequences were identified
-
STEP 1 - Patient must have standard risk MM as defined by the Revised International Staging System (RISS) stage I or II
- NOTE: R-ISS stage is based on serum beta2 microglobulin, albumin and lactate dehydrogenase (LDH) levels along with presence of chromosomal abnormalities (CA) detected by interphase fluorescent in situ hybridization (iFISH). Presence of del(17p), t(4;14), and/or t(14;16) is considered high risk and absence of these, including any other findings, are standard risk
-
R-ISS stage
- Stage I: ISS stage I [beta2 macroglobulin < 3.5 mg/L, albumin > 3.5 g/dL] AND standard-risk CA AND normal LDH
- Stage II: Not R-ISS stage I or III
- Stage III: ISS stage III [beta2 macroglobulin > 5.5 mg/L] AND high-risk CA OR high LDH (> upper limit of normal) [patients with stage III are ineligible]
-
STEP 1 - Patient must have measurable or evaluable disease as defined by having one or more of the following, obtained within 28 days prior to registration:
- >= 1 g/dL monoclonal protein (M-protein) on serum protein electrophoresis
- >= 200 mg/24 hours of monoclonal protein on a 24-hour urine protein electrophoresis
- Involved free light chain >= 10 mg/dL or >= 100 mg/L AND abnormal serum immunoglobulin kappa to lambda free light chain ratio (< 0.26 or > 1.65)
- Monoclonal bone marrow plasmacytosis >= 30% (evaluable disease)
-
STEP 1 - Patients must have a serum protein electrophoresis (SPEP), urine protein electrophoresis (UPEP), and serum free light chain (FLC) assay performed within 28 days prior to registration. In addition, a bone marrow biopsy and/or aspirate is required within 28 days if bone marrow is being followed for response
- NOTE: UPEP (on a 24-hour collection) is required, no substitute method is acceptable. Urine must be followed monthly if the baseline urine M-spike is >= 200 mg/24 hr. Please note that if both serum and urine M-components are present, both must be followed in order to evaluate response
- NOTE: The serum free light chain test is required to be done if the patient does not have measurable disease in the serum or urine. Measurable disease in the serum is defined as having a serum M-spike >= 1 g/dL. Measurable disease in the urine is defined as having a urine M-spike >= 200 mg/24 hr
- STEP 1 - Calculated creatinine clearance > 30 mL/min (obtained =< 14 days prior to Step 1 registration)
- STEP 1 - Absolute neutrophil count (ANC) >= 1000/mm^3 (obtained =< 14 days prior to Step 1 registration)
- STEP 1 - Untransfused platelet count >= 75,000/mm^3 (obtained =< 14 days prior to Step 1 registration)
- STEP 1 - Hemoglobin >= 8.0 g/dL (obtained =< 14 days prior to Step 1 registration)
- STEP 1 - Total bilirubin =< 1.5 x ULN (institutional upper limit of normal) (obtained =< 14 days prior to Step 1 registration)
- STEP 1 - Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 3 x ULN (obtained =< 14 days prior to Step 1 registration)
- STEP 1 - Patient must have received no more than one cycle (28 days or less) of prior chemotherapy and no more than 160 mg of prior dexamethasone (or equivalent dose of prednisone) for treatment of symptomatic myeloma. Patient must not have been exposed to daratumumab for treatment of symptomatic myeloma. Prior radiation therapy to symptomatic lesions is allowed provided there are no residual toxicity related to radiation and blood counts meet the study requirements. Radiation treatment must be completed at least 14 days prior to Step 1 registration
- STEP 1 - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization are eligible for this trial
- STEP 1 - For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated
- STEP 1 - Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
- STEP 1 - Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
- STEP 1 - Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better. Patients must not have evidence of current uncontrolled cardiovascular conditions, including hypertension, cardiac arrhythmias, congestive heart failure, unstable angina, or myocardial infarction within 6 months prior to Step 1 registration
- STEP 1 - Patient may have a history of current or previous deep vein thrombosis (DVT) or pulmonary embolism (PE) but must be willing to take some form of anti-coagulation as prophylaxis if they are not currently on full-dose anticoagulation
- STEP 1 - Patients with a history of chronic obstructive pulmonary disease (COPD) must have FEV1 testing done within 28 days prior to Step 1 registration and the forced expiratory volume in 1 second (FEV1) must be > 50% of predicted normal
- STEP 2 - Institution must have received Tracking (MRD) test results from Adaptive Biotechnologies
- STEP 2 - Patient must have completed the Step 1 Induction phase of this protocol without experiencing progression
- STEP 2 - Patient must be registered to Step 2 within 8 weeks of completing Step 1 Induction Treatment, counting from last day of completion of last cycle
- STEP 2 - Patient must have an ECOG performance status (PS) of 0-2 (PS 3 allowed if secondary to pain)
- STEP 2 - Any adverse event(s) related to Step 1 Induction Treatment must have resolved to grade 2 or less
- STEP 2 - Hemoglobin >= 8 g/dL (obtained within 14 days prior to Step 2 randomization)
- STEP 2 - Platelet count >= 50,000/mm^3 (obtained within 14 days prior to Step 2 randomization)
- STEP 2 - Absolute neutrophil count (ANC) >= 1000/mm^3 (obtained within 14 days prior to Step 2 randomization)
- STEP 2 - Calculated creatinine clearance >= 30 mL/min (obtained within 14 days prior to Step 2 randomization)
- STEP 2 - Total bilirubin =< 1.5 x ULN (Institutional upper limit of normal) (obtained within 14 days prior to Step 2 randomization)
- STEP 2 - ALT and AST < 3 x ULN (obtained within 14 days prior to Step 2 randomization)
Exclusion Criteria:
- STEP 0 - Patient must not have any known allergies, hypersensitivity, or intolerance to corticosteroids, monoclonal antibodies or human proteins, or their excipients (refer to respective package inserts or Investigator's Brochure), or known sensitivity to mammalian-derived products
-
STEP 1 - Women must not be pregnant or breast-feeding due to the potential harm and teratogenic effects to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All females of childbearing potential must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to Step 1 registration to rule out pregnancy and again within 24 hours prior to the first dose of lenalidomide. Females of childbearing potential must also agree to ongoing pregnancy testing while on protocol treatment. A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has achieved menarche at some point,
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
- STEP 1 - Women of childbearing potential must not expect to conceive children by using accepted and effective method(s) of contraception (for this protocol defined as the use of TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting protocol treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 3 months days after the last dose of protocol treatment) OR by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception). Men must not expect to father children by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception) OR use a latex condom during sexual contact with a female of child bearing potential while participating in the study and for at least 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Men must also agree to abstain from donating sperm while on study treatment and for 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Both women and men must both agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment
- STEP 1 - Patient must not have peripheral neuropathy >= grade 2 on clinical examination or grade 1 with pain at time of Step 1 registration
- STEP 1 - Patient must not have any serious medical or psychiatric illness that could, in the investigator's opinion, potentially interfere with the completion of treatment according to this protocol
-
STEP 1 - Patient must not have moderate or severe persistent asthma within the past 2 years, or uncontrolled asthma of any classification
- NOTE: Patients who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed to register
-
STEP 1 - Patient must not receive any other concurrent chemotherapy, or any ancillary therapy considered investigational while on this protocol
- NOTE: Bisphosphonates are considered to be supportive care rather than therapy, and are thus allowed while on protocol treatment
- STEP 2 - Patient must not have received any non-protocol therapy outside of the assigned Step 1 Induction treatment including stem cell transplant
-
STEP 2 - Women must not be pregnant or breast-feeding due to the potential harm and teratogenic effects to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All females of childbearing potential must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to Step 2 randomization to rule out pregnancy and again within 24 hours prior to the first dose of lenalidomide. Females of childbearing potential must also agree to ongoing pregnancy testing while on protocol treatment. A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has achieved menarche at some point,
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
- STEP 2 - Women of childbearing potential must not expect to conceive children by using accepted and effective method(s) of contraception (for this protocol defined as the use of TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting protocol treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 3 months days after the last dose of protocol treatment) OR by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception).
Men must not expect to father children by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception) OR use a latex condom during sexual contact with a female of child bearing potential while participating in the study and for at least 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Men must also agree to abstain from donating sperm while on study treatment and for 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Both women and men must both agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04566328
Locations
Show 460 study locations
Hide 460 study locations
| United States, Alaska | |
| Anchorage Associates in Radiation Medicine | Recruiting |
| Anchorage, Alaska, United States, 98508 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Anchorage Radiation Therapy Center | Recruiting |
| Anchorage, Alaska, United States, 99504 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Alaska Breast Care and Surgery LLC | Recruiting |
| Anchorage, Alaska, United States, 99508 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Alaska Oncology and Hematology LLC | Recruiting |
| Anchorage, Alaska, United States, 99508 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Alaska Women's Cancer Care | Recruiting |
| Anchorage, Alaska, United States, 99508 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Anchorage Oncology Centre | Recruiting |
| Anchorage, Alaska, United States, 99508 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Katmai Oncology Group | Recruiting |
| Anchorage, Alaska, United States, 99508 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Alaska Medical Center | Recruiting |
| Anchorage, Alaska, United States, 99508 | |
| Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| United States, Arizona | |
| Cancer Center at Saint Joseph's | Recruiting |
| Phoenix, Arizona, United States, 85004 | |
| Contact: Site Public Contact 602-406-0777 CancerInstitute@DignityHealth.org | |
| Principal Investigator: Richard L. Deming | |
| University of Arizona Cancer Center-Orange Grove Campus | Recruiting |
| Tucson, Arizona, United States, 85704 | |
| Contact: Site Public Contact 520-694-8900 | |
| Principal Investigator: Muhammad Husnain | |
| Banner University Medical Center - Tucson | Recruiting |
| Tucson, Arizona, United States, 85719 | |
| Contact: Site Public Contact aselegue@email.arizona.edu | |
| Principal Investigator: Muhammad Husnain | |
| University of Arizona Cancer Center-North Campus | Recruiting |
| Tucson, Arizona, United States, 85719 | |
| Contact: Site Public Contact 800-327-2873 | |
| Principal Investigator: Muhammad Husnain | |
| United States, Arkansas | |
| Mercy Hospital Fort Smith | Recruiting |
| Fort Smith, Arkansas, United States, 72903 | |
| Contact: Site Public Contact 800-378-9373 | |
| Principal Investigator: Jay W. Carlson | |
| CHI Saint Vincent Cancer Center Hot Springs | Recruiting |
| Hot Springs, Arkansas, United States, 71913 | |
| Contact: Site Public Contact 855-313-2409 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| United States, California | |
| Mission Hope Medical Oncology - Arroyo Grande | Recruiting |
| Arroyo Grande, California, United States, 93420 | |
| Contact: Site Public Contact 805-219-4673 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Providence Saint Joseph Medical Center/Disney Family Cancer Center | Recruiting |
| Burbank, California, United States, 91505 | |
| Contact: Site Public Contact 818-847-4793 Najee.Boucher@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Pacific Central Coast Health Center-San Luis Obispo | Recruiting |
| San Luis Obispo, California, United States, 93401 | |
| Contact: Site Public Contact 805-219-4673 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Mission Hope Medical Oncology - Santa Maria | Recruiting |
| Santa Maria, California, United States, 93444 | |
| Contact: Site Public Contact 805-219-4673 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| United States, Colorado | |
| Penrose-Saint Francis Healthcare | Recruiting |
| Colorado Springs, Colorado, United States, 80907 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Rocky Mountain Cancer Centers-Penrose | Recruiting |
| Colorado Springs, Colorado, United States, 80907 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Saint Francis Cancer Center | Recruiting |
| Colorado Springs, Colorado, United States, 80923 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Porter Adventist Hospital | Recruiting |
| Denver, Colorado, United States, 80210 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Mercy Medical Center | Recruiting |
| Durango, Colorado, United States, 81301 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Southwest Oncology PC | Recruiting |
| Durango, Colorado, United States, 81301 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Saint Anthony Hospital | Recruiting |
| Lakewood, Colorado, United States, 80228 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Littleton Adventist Hospital | Recruiting |
| Littleton, Colorado, United States, 80122 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Longmont United Hospital | Recruiting |
| Longmont, Colorado, United States, 80501 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Rocky Mountain Cancer Centers-Longmont | Recruiting |
| Longmont, Colorado, United States, 80501 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Parker Adventist Hospital | Recruiting |
| Parker, Colorado, United States, 80138 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| Saint Mary Corwin Medical Center | Recruiting |
| Pueblo, Colorado, United States, 81004 | |
| Contact: Site Public Contact 719-776-6550 ResearchTracking@Centura.Org | |
| Principal Investigator: Richard L. Deming | |
| United States, Connecticut | |
| Smilow Cancer Hospital-Derby Care Center | Recruiting |
| Derby, Connecticut, United States, 06418 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital Care Center-Fairfield | Recruiting |
| Fairfield, Connecticut, United States, 06824 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital Care Center at Glastonbury | Recruiting |
| Glastonbury, Connecticut, United States, 06033 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital Care Center at Greenwich | Recruiting |
| Greenwich, Connecticut, United States, 06830 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital Care Center - Guiford | Recruiting |
| Guilford, Connecticut, United States, 06437 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital Care Center at Saint Francis | Recruiting |
| Hartford, Connecticut, United States, 06105 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Center/Yale-New Haven Hospital | Recruiting |
| New Haven, Connecticut, United States, 06510 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Yale University | Recruiting |
| New Haven, Connecticut, United States, 06520 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Yale-New Haven Hospital North Haven Medical Center | Recruiting |
| North Haven, Connecticut, United States, 06473 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital-Orange Care Center | Recruiting |
| Orange, Connecticut, United States, 06477 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital-Torrington Care Center | Recruiting |
| Torrington, Connecticut, United States, 06790 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital Care Center-Trumbull | Recruiting |
| Trumbull, Connecticut, United States, 06611 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital-Waterbury Care Center | Recruiting |
| Waterbury, Connecticut, United States, 06708 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| Smilow Cancer Hospital Care Center - Waterford | Recruiting |
| Waterford, Connecticut, United States, 06385 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| United States, Delaware | |
| Beebe South Coastal Health Campus | Recruiting |
| Frankford, Delaware, United States, 19945 | |
| Contact: Site Public Contact 302-645-3100 Dmiskin@Beebehealthcare.org | |
| Principal Investigator: Gregory A. Masters | |
| Beebe Medical Center | Recruiting |
| Lewes, Delaware, United States, 19958 | |
| Contact: Site Public Contact 302-645-3770 Dmiskin@Beebehealthcare.org | |
| Principal Investigator: Gregory A. Masters | |
| Delaware Clinical and Laboratory Physicians PA | Recruiting |
| Newark, Delaware, United States, 19713 | |
| Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
| Principal Investigator: Gregory A. Masters | |
| Helen F Graham Cancer Center | Recruiting |
| Newark, Delaware, United States, 19713 | |
| Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
| Principal Investigator: Gregory A. Masters | |
| Medical Oncology Hematology Consultants PA | Recruiting |
| Newark, Delaware, United States, 19713 | |
| Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
| Principal Investigator: Gregory A. Masters | |
| Christiana Care Health System-Christiana Hospital | Recruiting |
| Newark, Delaware, United States, 19718 | |
| Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
| Principal Investigator: Gregory A. Masters | |
| Beebe Health Campus | Recruiting |
| Rehoboth Beach, Delaware, United States, 19971 | |
| Contact: Site Public Contact 302-645-3100 Dmiskin@Beebehealthcare.org | |
| Principal Investigator: Gregory A. Masters | |
| TidalHealth Nanticoke / Allen Cancer Center | Suspended |
| Seaford, Delaware, United States, 19973 | |
| Christiana Care Health System-Wilmington Hospital | Recruiting |
| Wilmington, Delaware, United States, 19801 | |
| Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
| Principal Investigator: Gregory A. Masters | |
| United States, Florida | |
| Holy Cross Hospital | Recruiting |
| Fort Lauderdale, Florida, United States, 33308 | |
| Contact: Site Public Contact 954-267-7748 | |
| Principal Investigator: Elie G. Dib | |
| Sacred Heart Hospital | Recruiting |
| Pensacola, Florida, United States, 32504 | |
| Contact: Site Public Contact 850-416-4611 eebrou@ascension.org | |
| Principal Investigator: Alexander W. Brown | |
| United States, Idaho | |
| Saint Alphonsus Cancer Care Center-Boise | Recruiting |
| Boise, Idaho, United States, 83706 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: John M. Schallenkamp | |
| Saint Luke's Cancer Institute - Boise | Recruiting |
| Boise, Idaho, United States, 83712 | |
| Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
| Principal Investigator: Alison K. Conlin | |
| Saint Alphonsus Cancer Care Center-Caldwell | Recruiting |
| Caldwell, Idaho, United States, 83605 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: John M. Schallenkamp | |
| Kootenai Health - Coeur d'Alene | Recruiting |
| Coeur d'Alene, Idaho, United States, 83814 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Walter Knox Memorial Hospital | Recruiting |
| Emmett, Idaho, United States, 83617 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: John M. Schallenkamp | |
| Saint Luke's Cancer Institute - Fruitland | Recruiting |
| Fruitland, Idaho, United States, 83619 | |
| Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
| Principal Investigator: Alison K. Conlin | |
| Idaho Urologic Institute-Meridian | Recruiting |
| Meridian, Idaho, United States, 83642 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: John M. Schallenkamp | |
| Saint Luke's Cancer Institute - Meridian | Recruiting |
| Meridian, Idaho, United States, 83642 | |
| Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
| Principal Investigator: Alison K. Conlin | |
| Saint Alphonsus Medical Center-Nampa | Recruiting |
| Nampa, Idaho, United States, 83686 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Saint Luke's Cancer Institute - Nampa | Recruiting |
| Nampa, Idaho, United States, 83686 | |
| Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
| Principal Investigator: Alison K. Conlin | |
| Kootenai Clinic Cancer Services - Post Falls | Recruiting |
| Post Falls, Idaho, United States, 83854 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Kootenai Cancer Clinic | Recruiting |
| Sandpoint, Idaho, United States, 83864 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Saint Luke's Cancer Institute - Twin Falls | Recruiting |
| Twin Falls, Idaho, United States, 83301 | |
| Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
| Principal Investigator: Alison K. Conlin | |
| United States, Illinois | |
| Saint Anthony's Health | Recruiting |
| Alton, Illinois, United States, 62002 | |
| Contact: Site Public Contact 618-463-5623 | |
| Principal Investigator: Jay W. Carlson | |
| Rush - Copley Medical Center | Recruiting |
| Aurora, Illinois, United States, 60504 | |
| Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
| Principal Investigator: Priyank P. Patel | |
| Illinois CancerCare-Bloomington | Recruiting |
| Bloomington, Illinois, United States, 61704 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Loyola Center for Health at Burr Ridge | Recruiting |
| Burr Ridge, Illinois, United States, 60527 | |
| Contact: Site Public Contact 708-216-9000 | |
| Principal Investigator: Patrick A. Hagen | |
| Illinois CancerCare-Canton | Recruiting |
| Canton, Illinois, United States, 61520 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Memorial Hospital of Carbondale | Recruiting |
| Carbondale, Illinois, United States, 62902 | |
| Contact: Site Public Contact 618-457-5200 clinical.research@sih.net | |
| Principal Investigator: Bryan A. Faller | |
| SIH Cancer Institute | Recruiting |
| Carterville, Illinois, United States, 62918 | |
| Contact: Site Public Contact 618-985-3333 clinical.research@sih.net | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Carthage | Recruiting |
| Carthage, Illinois, United States, 62321 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Centralia Oncology Clinic | Recruiting |
| Centralia, Illinois, United States, 62801 | |
| Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
| Principal Investigator: Bryan A. Faller | |
| University of Illinois | Recruiting |
| Chicago, Illinois, United States, 60612 | |
| Contact: Site Public Contact 312-355-3046 | |
| Principal Investigator: Pritesh Patel | |
| Carle on Vermilion | Recruiting |
| Danville, Illinois, United States, 61832 | |
| Contact: Site Public Contact 800-446-5532 Research@carle.com | |
| Principal Investigator: Priyank P. Patel | |
| Cancer Care Specialists of Illinois - Decatur | Recruiting |
| Decatur, Illinois, United States, 62526 | |
| Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
| Principal Investigator: Bryan A. Faller | |
| Decatur Memorial Hospital | Recruiting |
| Decatur, Illinois, United States, 62526 | |
| Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
| Principal Investigator: Bryan A. Faller | |
| Northwestern Medicine Cancer Center Kishwaukee | Recruiting |
| DeKalb, Illinois, United States, 60115 | |
| Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
| Principal Investigator: Robert M. Eisner | |
| Illinois CancerCare-Dixon | Recruiting |
| Dixon, Illinois, United States, 61021 | |
| Contact: Site Public Contact 815-285-7800 | |
| Principal Investigator: Bryan A. Faller | |
| Carle Physician Group-Effingham | Recruiting |
| Effingham, Illinois, United States, 62401 | |
| Contact: Site Public Contact 800-446-5532 Research@carle.com | |
| Principal Investigator: Priyank P. Patel | |
| Crossroads Cancer Center | Recruiting |
| Effingham, Illinois, United States, 62401 | |
| Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Eureka | Recruiting |
| Eureka, Illinois, United States, 61530 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Galesburg | Recruiting |
| Galesburg, Illinois, United States, 61401 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Western Illinois Cancer Treatment Center | Recruiting |
| Galesburg, Illinois, United States, 61401 | |
| Contact: Site Public Contact 309-344-2831 | |
| Principal Investigator: Bryan A. Faller | |
| Northwestern Medicine Cancer Center Delnor | Recruiting |
| Geneva, Illinois, United States, 60134 | |
| Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
| Principal Investigator: Robert M. Eisner | |
| Loyola Medicine Homer Glen | Recruiting |
| Homer Glen, Illinois, United States, 60491 | |
| Contact: Site Public Contact 708-216-9000 | |
| Principal Investigator: Patrick A. Hagen | |
| Illinois CancerCare-Kewanee Clinic | Recruiting |
| Kewanee, Illinois, United States, 61443 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Macomb | Recruiting |
| Macomb, Illinois, United States, 61455 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Carle Physician Group-Mattoon/Charleston | Recruiting |
| Mattoon, Illinois, United States, 61938 | |
| Contact: Site Public Contact 800-446-5532 Research@carle.com | |
| Principal Investigator: Priyank P. Patel | |
| Loyola University Medical Center | Recruiting |
| Maywood, Illinois, United States, 60153 | |
| Contact: Site Public Contact 708-226-4357 | |
| Principal Investigator: Patrick A. Hagen | |
| Marjorie Weinberg Cancer Center at Loyola-Gottlieb | Recruiting |
| Melrose Park, Illinois, United States, 60160 | |
| Contact: Site Public Contact 708-450-4554 | |
| Principal Investigator: Patrick A. Hagen | |
| Good Samaritan Regional Health Center | Recruiting |
| Mount Vernon, Illinois, United States, 62864 | |
| Contact: Site Public Contact 618-242-4600 | |
| Principal Investigator: Jay W. Carlson | |
| Cancer Care Center of O'Fallon | Recruiting |
| O'Fallon, Illinois, United States, 62269 | |
| Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Ottawa Clinic | Recruiting |
| Ottawa, Illinois, United States, 61350 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Pekin | Recruiting |
| Pekin, Illinois, United States, 61554 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Peoria | Recruiting |
| Peoria, Illinois, United States, 61615 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Methodist Medical Center of Illinois | Recruiting |
| Peoria, Illinois, United States, 61636 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Peru | Recruiting |
| Peru, Illinois, United States, 61354 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Valley Radiation Oncology | Recruiting |
| Peru, Illinois, United States, 61354 | |
| Contact: Site Public Contact 815-664-4141 | |
| Principal Investigator: Bryan A. Faller | |
| Illinois CancerCare-Princeton | Recruiting |
| Princeton, Illinois, United States, 61356 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Southern Illinois University School of Medicine | Recruiting |
| Springfield, Illinois, United States, 62702 | |
| Contact: Site Public Contact 217-545-7929 | |
| Principal Investigator: Bryan A. Faller | |
| Springfield Clinic | Recruiting |
| Springfield, Illinois, United States, 62702 | |
| Contact: Site Public Contact 800-444-7541 | |
| Principal Investigator: Bryan A. Faller | |
| Memorial Medical Center | Recruiting |
| Springfield, Illinois, United States, 62781 | |
| Contact: Site Public Contact 217-788-3528 | |
| Principal Investigator: Bryan A. Faller | |
| Carle Cancer Center | Recruiting |
| Urbana, Illinois, United States, 61801 | |
| Contact: Site Public Contact 800-446-5532 Research@carle.com | |
| Principal Investigator: Priyank P. Patel | |
| The Carle Foundation Hospital | Recruiting |
| Urbana, Illinois, United States, 61801 | |
| Contact: Site Public Contact 800-446-5532 Research@carle.com | |
| Principal Investigator: Priyank P. Patel | |
| Northwestern Medicine Cancer Center Warrenville | Recruiting |
| Warrenville, Illinois, United States, 60555 | |
| Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
| Principal Investigator: Robert M. Eisner | |
| Illinois CancerCare - Washington | Recruiting |
| Washington, Illinois, United States, 61571 | |
| Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
| Principal Investigator: Bryan A. Faller | |
| Rush-Copley Healthcare Center | Recruiting |
| Yorkville, Illinois, United States, 60560 | |
| Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
| Principal Investigator: Priyank P. Patel | |
| United States, Indiana | |
| IU Health North Hospital | Not yet recruiting |
| Carmel, Indiana, United States, 46032 | |
| Contact: Chelsea Young 317-278-5621 youngchs@iu.edu | |
| Principal Investigator: Rafat Abonour | |
| Indiana University/Melvin and Bren Simon Cancer Center | Not yet recruiting |
| Indianapolis, Indiana, United States, 46202 | |
| Contact: Chelsea Young 317-278-5621 youngchs@iu.edu | |
| Principal Investigator: Rafat Abonour | |
| IU Health Methodist Hospital | Not yet recruiting |
| Indianapolis, Indiana, United States, 46202 | |
| Contact: Chelsea Young 317-278-5621 youngchs@iu.edu | |
| Principal Investigator: Rafat Abonour | |
| Reid Health | Recruiting |
| Richmond, Indiana, United States, 47374 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| United States, Iowa | |
| Mary Greeley Medical Center | Recruiting |
| Ames, Iowa, United States, 50010 | |
| Contact: Site Public Contact 515-956-4132 | |
| Principal Investigator: Debra M. Prow | |
| McFarland Clinic PC - Ames | Recruiting |
| Ames, Iowa, United States, 50010 | |
| Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
| Principal Investigator: Debra M. Prow | |
| McFarland Clinic PC-Boone | Recruiting |
| Boone, Iowa, United States, 50036 | |
| Contact: Site Public Contact 515-956-4132 | |
| Principal Investigator: Debra M. Prow | |
| Saint Anthony Regional Hospital | Recruiting |
| Carroll, Iowa, United States, 51401 | |
| Contact: Site Public Contact 515-689-7658 sbenson@iora.org | |
| Principal Investigator: Joshua Lukenbill | |
| Mercy Hospital | Recruiting |
| Cedar Rapids, Iowa, United States, 52403 | |
| Contact: Site Public Contact 319-365-4673 | |
| Principal Investigator: Deborah W. Wilbur | |
| Oncology Associates at Mercy Medical Center | Recruiting |
| Cedar Rapids, Iowa, United States, 52403 | |
| Contact: Site Public Contact 319-363-2690 | |
| Principal Investigator: Deborah W. Wilbur | |
| Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
| Clive, Iowa, United States, 50325 | |
| Contact: Site Public Contact 515-643-2196 cancerresearch@mercydesmoines.org | |
| Principal Investigator: Richard L. Deming | |
| Mercy Cancer Center-West Lakes | Recruiting |
| Clive, Iowa, United States, 50325 | |
| Contact: Site Public Contact 515-643-2196 cancerresearch@mercydesmoines.org | |
| Principal Investigator: Richard L. Deming | |
| Alegent Health Mercy Hospital | Recruiting |
| Council Bluffs, Iowa, United States, 51503 | |
| Contact: Site Public Contact 402-717-1510 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Greater Regional Medical Center | Recruiting |
| Creston, Iowa, United States, 50801 | |
| Contact: Site Public Contact 515-643-2196 cancerresearch@mercydesmoines.org | |
| Principal Investigator: Richard L. Deming | |
| Iowa Methodist Medical Center | Recruiting |
| Des Moines, Iowa, United States, 50309 | |
| Contact: Site Public Contact 515-241-6727 | |
| Principal Investigator: Joshua Lukenbill | |
| Medical Oncology and Hematology Associates-Des Moines | Recruiting |
| Des Moines, Iowa, United States, 50309 | |
| Contact: Site Public Contact 515-282-2921 | |
| Principal Investigator: Joshua Lukenbill | |
| Broadlawns Medical Center | Recruiting |
| Des Moines, Iowa, United States, 50314 | |
| Contact: Site Public Contact 515-282-2200 | |
| Principal Investigator: Joshua Lukenbill | |
| Medical Oncology and Hematology Associates-Laurel | Recruiting |
| Des Moines, Iowa, United States, 50314 | |
| Contact: Site Public Contact 515-643-2196 cancerresearch@mercydesmoines.org | |
| Principal Investigator: Richard L. Deming | |
| Mercy Medical Center - Des Moines | Recruiting |
| Des Moines, Iowa, United States, 50314 | |
| Contact: Site Public Contact 515-643-2196 cancerresearch@mercydesmoines.org | |
| Principal Investigator: Richard L. Deming | |
| Iowa Lutheran Hospital | Recruiting |
| Des Moines, Iowa, United States, 50316 | |
| Contact: Site Public Contact 515-241-8704 | |
| Principal Investigator: Joshua Lukenbill | |
| McFarland Clinic PC-Trinity Cancer Center | Recruiting |
| Fort Dodge, Iowa, United States, 50501 | |
| Contact: Site Public Contact 515-956-4132 | |
| Principal Investigator: Debra M. Prow | |
| Trinity Regional Medical Center | Recruiting |
| Fort Dodge, Iowa, United States, 50501 | |
| Contact: Site Public Contact 515-574-8302 | |
| Principal Investigator: Joshua Lukenbill | |
| McFarland Clinic PC-Jefferson | Recruiting |
| Jefferson, Iowa, United States, 50129 | |
| Contact: Site Public Contact 515-956-4132 | |
| Principal Investigator: Debra M. Prow | |
| McFarland Clinic PC-Marshalltown | Recruiting |
| Marshalltown, Iowa, United States, 50158 | |
| Contact: Site Public Contact 515-956-4132 | |
| Principal Investigator: Debra M. Prow | |
| Methodist West Hospital | Recruiting |
| West Des Moines, Iowa, United States, 50266-7700 | |
| Contact: Site Public Contact 515-343-1000 | |
| Principal Investigator: Joshua Lukenbill | |
| Mercy Medical Center-West Lakes | Recruiting |
| West Des Moines, Iowa, United States, 50266 | |
| Contact: Site Public Contact 515-643-2196 cancerresearch@mercydesmoines.org | |
| Principal Investigator: Richard L. Deming | |
| United States, Kansas | |
| Central Care Cancer Center - Garden City | Recruiting |
| Garden City, Kansas, United States, 67846 | |
| Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
| Principal Investigator: Jay W. Carlson | |
| Central Care Cancer Center - Great Bend | Recruiting |
| Great Bend, Kansas, United States, 67530 | |
| Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
| Principal Investigator: Jay W. Carlson | |
| United States, Kentucky | |
| Flaget Memorial Hospital | Recruiting |
| Bardstown, Kentucky, United States, 40004 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Commonwealth Cancer Center-Corbin | Recruiting |
| Corbin, Kentucky, United States, 40701 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Saint Joseph Radiation Oncology Resource Center | Recruiting |
| Lexington, Kentucky, United States, 40504 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Saint Joseph Hospital East | Recruiting |
| Lexington, Kentucky, United States, 40509 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Saint Joseph London | Recruiting |
| London, Kentucky, United States, 40741 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Jewish Hospital | Recruiting |
| Louisville, Kentucky, United States, 40202 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Saints Mary and Elizabeth Hospital | Recruiting |
| Louisville, Kentucky, United States, 40215 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Jewish Hospital Medical Center Northeast | Recruiting |
| Louisville, Kentucky, United States, 40245 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Jewish Hospital Medical Center South | Recruiting |
| Shepherdsville, Kentucky, United States, 40165 | |
| Contact: Site Public Contact 859-629-7169 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| United States, Louisiana | |
| Ochsner LSU Health Monroe Medical Center | Recruiting |
| Monroe, Louisiana, United States, 71202 | |
| Contact: Site Public Contact 318-813-1404 LPost@lsuhsc.edu | |
| Principal Investigator: Samip Master | |
| LSU Health Sciences Center at Shreveport | Recruiting |
| Shreveport, Louisiana, United States, 71103 | |
| Contact: Site Public Contact 318-813-1404 LPost@lsuhsc.edu | |
| Principal Investigator: Samip Master | |
| United States, Maryland | |
| Frederick Memorial Hospital | Recruiting |
| Frederick, Maryland, United States, 21701 | |
| Contact: Site Public Contact 240-566-3584 clinicaltrials@fmh.org | |
| Principal Investigator: Patrick J. Mansky | |
| FMH James M Stockman Cancer Institute | Recruiting |
| Frederick, Maryland, United States, 21702 | |
| Contact: Site Public Contact 301-668-7043 | |
| Principal Investigator: Patrick J. Mansky | |
| United States, Massachusetts | |
| Tufts Medical Center | Recruiting |
| Boston, Massachusetts, United States, 02111 | |
| Contact: Site Public Contact 617-636-5000 ContactUsCancerCenter@TuftsMedicalCenter.org | |
| Principal Investigator: Raymond L. Comenzo | |
| United States, Michigan | |
| Hickman Cancer Center | Recruiting |
| Adrian, Michigan, United States, 49221 | |
| Contact: Site Public Contact 517-265-0116 | |
| Principal Investigator: Rex B. Mowat | |
| Saint Joseph Mercy Hospital | Recruiting |
| Ann Arbor, Michigan, United States, 48106 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Bronson Battle Creek | Recruiting |
| Battle Creek, Michigan, United States, 49017 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| IHA Hematology Oncology Consultants-Brighton | Recruiting |
| Brighton, Michigan, United States, 48114 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint Joseph Mercy Brighton | Recruiting |
| Brighton, Michigan, United States, 48114 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| IHA Hematology Oncology Consultants-Canton | Recruiting |
| Canton, Michigan, United States, 48188 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint Joseph Mercy Canton | Recruiting |
| Canton, Michigan, United States, 48188 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Caro Cancer Center | Recruiting |
| Caro, Michigan, United States, 48723 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| IHA Hematology Oncology Consultants-Chelsea | Recruiting |
| Chelsea, Michigan, United States, 48118 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint Joseph Mercy Chelsea | Recruiting |
| Chelsea, Michigan, United States, 48118 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Hematology Oncology Consultants-Clarkston | Recruiting |
| Clarkston, Michigan, United States, 48346 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Newland Medical Associates-Clarkston | Recruiting |
| Clarkston, Michigan, United States, 48346 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Ascension Saint John Hospital | Recruiting |
| Detroit, Michigan, United States, 48236 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
| East China Township, Michigan, United States, 48054 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Genesee Cancer and Blood Disease Treatment Center | Recruiting |
| Flint, Michigan, United States, 48503 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Genesee Hematology Oncology PC | Recruiting |
| Flint, Michigan, United States, 48503 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Genesys Hurley Cancer Institute | Recruiting |
| Flint, Michigan, United States, 48503 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Hurley Medical Center | Recruiting |
| Flint, Michigan, United States, 48503 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Helen DeVos Children's Hospital at Spectrum Health | Recruiting |
| Grand Rapids, Michigan, United States, 49503 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Mercy Health Saint Mary's | Recruiting |
| Grand Rapids, Michigan, United States, 49503 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Spectrum Health at Butterworth Campus | Recruiting |
| Grand Rapids, Michigan, United States, 49503 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Academic Hematology Oncology Specialists | Recruiting |
| Grosse Pointe Woods, Michigan, United States, 48236 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
| Grosse Pointe Woods, Michigan, United States, 48236 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
| Grosse Pointe Woods, Michigan, United States, 48236 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Bronson Methodist Hospital | Recruiting |
| Kalamazoo, Michigan, United States, 49007 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| West Michigan Cancer Center | Recruiting |
| Kalamazoo, Michigan, United States, 49007 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Ascension Borgess Cancer Center | Recruiting |
| Kalamazoo, Michigan, United States, 49009 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Borgess Medical Center | Recruiting |
| Kalamazoo, Michigan, United States, 49048 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Sparrow Hospital | Recruiting |
| Lansing, Michigan, United States, 48912 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Hope Cancer Clinic | Recruiting |
| Livonia, Michigan, United States, 48154 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint Mary Mercy Hospital | Recruiting |
| Livonia, Michigan, United States, 48154 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
| Macomb, Michigan, United States, 48044 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Michigan Breast Specialists-Macomb Township | Recruiting |
| Macomb, Michigan, United States, 48044 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint Mary's Oncology/Hematology Associates of Marlette | Recruiting |
| Marlette, Michigan, United States, 48453 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Toledo Clinic Cancer Centers-Monroe | Recruiting |
| Monroe, Michigan, United States, 48162 | |
| Contact: Site Public Contact 800-444-3561 | |
| Principal Investigator: Rex B. Mowat | |
| Mercy Health Mercy Campus | Recruiting |
| Muskegon, Michigan, United States, 49444 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Lakeland Hospital Niles | Recruiting |
| Niles, Michigan, United States, 49120 | |
| Contact: Site Public Contact 616-391-1230 | |
| Principal Investigator: Kathleen J. Yost | |
| Cancer and Hematology Centers of Western Michigan - Norton Shores | Recruiting |
| Norton Shores, Michigan, United States, 49444 | |
| Contact: Site Public Contact 616-391-1230 connie.szczepanek@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Ascension Providence Hospitals - Novi | Recruiting |
| Novi, Michigan, United States, 48374 | |
| Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
| Principal Investigator: Anibal Drelichman | |
| 21st Century Oncology-Pontiac | Recruiting |
| Pontiac, Michigan, United States, 48341 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Hope Cancer Center | Recruiting |
| Pontiac, Michigan, United States, 48341 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Newland Medical Associates-Pontiac | Recruiting |
| Pontiac, Michigan, United States, 48341 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint Joseph Mercy Oakland | Recruiting |
| Pontiac, Michigan, United States, 48341 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Spectrum Health Reed City Hospital | Recruiting |
| Reed City, Michigan, United States, 49677 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Great Lakes Cancer Management Specialists-Rochester Hills | Suspended |
| Rochester Hills, Michigan, United States, 48309 | |
| Ascension Saint Mary's Hospital | Recruiting |
| Saginaw, Michigan, United States, 48601 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Oncology Hematology Associates of Saginaw Valley PC | Recruiting |
| Saginaw, Michigan, United States, 48604 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Lakeland Medical Center Saint Joseph | Recruiting |
| Saint Joseph, Michigan, United States, 49085 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Marie Yeager Cancer Center | Recruiting |
| Saint Joseph, Michigan, United States, 49085 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Ascension Providence Hospitals - Southfield | Recruiting |
| Southfield, Michigan, United States, 48075 | |
| Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
| Principal Investigator: Anibal Drelichman | |
| Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
| Sterling Heights, Michigan, United States, 48312 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Ascension Saint Joseph Hospital | Recruiting |
| Tawas City, Michigan, United States, 48764 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Munson Medical Center | Recruiting |
| Traverse City, Michigan, United States, 49684 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Advanced Breast Care Center PLLC | Recruiting |
| Warren, Michigan, United States, 48088 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
| Warren, Michigan, United States, 48093 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Macomb Hematology Oncology PC | Recruiting |
| Warren, Michigan, United States, 48093 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Michigan Breast Specialists-Warren | Recruiting |
| Warren, Michigan, United States, 48093 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint John Macomb-Oakland Hospital | Recruiting |
| Warren, Michigan, United States, 48093 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Saint Mary's Oncology/Hematology Associates of West Branch | Recruiting |
| West Branch, Michigan, United States, 48661 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Metro Health Hospital | Recruiting |
| Wyoming, Michigan, United States, 49519 | |
| Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
| Principal Investigator: Kathleen J. Yost | |
| Huron Gastroenterology PC | Recruiting |
| Ypsilanti, Michigan, United States, 48106 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
| Ypsilanti, Michigan, United States, 48197 | |
| Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| United States, Minnesota | |
| Sanford Joe Lueken Cancer Center | Recruiting |
| Bemidji, Minnesota, United States, 56601 | |
| Contact: Site Public Contact 218-333-5000 OncologyClinicalTrialsFargo@sanfordhealth.org | |
| Principal Investigator: Preston D. Steen | |
| Fairview Ridges Hospital | Recruiting |
| Burnsville, Minnesota, United States, 55337 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Minnesota Oncology - Burnsville | Recruiting |
| Burnsville, Minnesota, United States, 55337 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Cambridge Medical Center | Recruiting |
| Cambridge, Minnesota, United States, 55008 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Mercy Hospital | Recruiting |
| Coon Rapids, Minnesota, United States, 55433 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Fairview Southdale Hospital | Recruiting |
| Edina, Minnesota, United States, 55435 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Unity Hospital | Recruiting |
| Fridley, Minnesota, United States, 55432 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Fairview Clinics and Surgery Center Maple Grove | Recruiting |
| Maple Grove, Minnesota, United States, 55369 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Minnesota Oncology Hematology PA-Maplewood | Recruiting |
| Maplewood, Minnesota, United States, 55109 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Saint John's Hospital - Healtheast | Recruiting |
| Maplewood, Minnesota, United States, 55109 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Abbott-Northwestern Hospital | Recruiting |
| Minneapolis, Minnesota, United States, 55407 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Hennepin County Medical Center | Recruiting |
| Minneapolis, Minnesota, United States, 55415 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Health Partners Inc | Recruiting |
| Minneapolis, Minnesota, United States, 55454 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Monticello Cancer Center | Recruiting |
| Monticello, Minnesota, United States, 55362 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| New Ulm Medical Center | Recruiting |
| New Ulm, Minnesota, United States, 56073 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Fairview Northland Medical Center | Recruiting |
| Princeton, Minnesota, United States, 55371 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| North Memorial Medical Health Center | Recruiting |
| Robbinsdale, Minnesota, United States, 55422 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Mayo Clinic in Rochester | Recruiting |
| Rochester, Minnesota, United States, 55905 | |
| Contact: Site Public Contact 855-776-0015 | |
| Principal Investigator: Shaji K. Kumar | |
| Park Nicollet Clinic - Saint Louis Park | Recruiting |
| Saint Louis Park, Minnesota, United States, 55416 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Regions Hospital | Recruiting |
| Saint Paul, Minnesota, United States, 55101 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| United Hospital | Recruiting |
| Saint Paul, Minnesota, United States, 55102 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Saint Francis Regional Medical Center | Recruiting |
| Shakopee, Minnesota, United States, 55379 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Lakeview Hospital | Recruiting |
| Stillwater, Minnesota, United States, 55082 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Sanford Thief River Falls Medical Center | Recruiting |
| Thief River Falls, Minnesota, United States, 56701 | |
| Contact: Site Public Contact 605-312-3320 | |
| Principal Investigator: Preston D. Steen | |
| Ridgeview Medical Center | Recruiting |
| Waconia, Minnesota, United States, 55387 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Rice Memorial Hospital | Recruiting |
| Willmar, Minnesota, United States, 56201 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Minnesota Oncology Hematology PA-Woodbury | Recruiting |
| Woodbury, Minnesota, United States, 55125 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| Fairview Lakes Medical Center | Recruiting |
| Wyoming, Minnesota, United States, 55092 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| United States, Missouri | |
| Saint Louis Cancer and Breast Institute-Ballwin | Recruiting |
| Ballwin, Missouri, United States, 63011 | |
| Contact: Site Public Contact 314-251-7058 | |
| Principal Investigator: Jay W. Carlson | |
| Central Care Cancer Center - Bolivar | Recruiting |
| Bolivar, Missouri, United States, 65613 | |
| Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
| Principal Investigator: Jay W. Carlson | |
| Cox Cancer Center Branson | Recruiting |
| Branson, Missouri, United States, 65616 | |
| Contact: Site Public Contact 417-269-4520 | |
| Principal Investigator: Jay W. Carlson | |
| Saint Francis Medical Center | Recruiting |
| Cape Girardeau, Missouri, United States, 63703 | |
| Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
| Principal Investigator: Bryan A. Faller | |
| Southeast Cancer Center | Recruiting |
| Cape Girardeau, Missouri, United States, 63703 | |
| Contact: Site Public Contact 573-651-5550 | |
| Principal Investigator: Bryan A. Faller | |
| Parkland Health Center - Farmington | Recruiting |
| Farmington, Missouri, United States, 63640 | |
| Contact: Site Public Contact 314-996-5569 | |
| Principal Investigator: Bryan A. Faller | |
| Capital Region Southwest Campus | Recruiting |
| Jefferson City, Missouri, United States, 65109 | |
| Contact: Site Public Contact 573-632-4814 swooden@mail.crmc.org | |
| Principal Investigator: Bryan A. Faller | |
| Freeman Health System | Recruiting |
| Joplin, Missouri, United States, 64804 | |
| Contact: Site Public Contact 417-347-4030 LJCrockett@freemanhealth.com | |
| Principal Investigator: Jay W. Carlson | |
| Mercy Hospital Joplin | Recruiting |
| Joplin, Missouri, United States, 64804 | |
| Contact: Site Public Contact 417-556-3074 esmeralda.carrillo@mercy.net | |
| Principal Investigator: Jay W. Carlson | |
| Delbert Day Cancer Institute at PCRMC | Recruiting |
| Rolla, Missouri, United States, 65401 | |
| Contact: Site Public Contact 573-458-7504 research@phelpshealth.org | |
| Principal Investigator: Jay W. Carlson | |
| Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
| Rolla, Missouri, United States, 65401 | |
| Contact: Site Public Contact 573-458-6379 | |
| Principal Investigator: Jay W. Carlson | |
| Heartland Regional Medical Center | Recruiting |
| Saint Joseph, Missouri, United States, 64506 | |
| Contact: Site Public Contact 816-271-7937 linda.schumacher@mymlc.com | |
| Principal Investigator: Jay W. Carlson | |
| Saint Louis Cancer and Breast Institute-South City | Recruiting |
| Saint Louis, Missouri, United States, 63109 | |
| Contact: Site Public Contact 314-353-1870 | |
| Principal Investigator: Jay W. Carlson | |
| Mercy Hospital South | Recruiting |
| Saint Louis, Missouri, United States, 63128 | |
| Contact: Site Public Contact janet.lesko@mercy.net | |
| Principal Investigator: Jay W. Carlson | |
| Missouri Baptist Medical Center | Recruiting |
| Saint Louis, Missouri, United States, 63131 | |
| Contact: Site Public Contact 314-996-5569 | |
| Principal Investigator: Bryan A. Faller | |
| Mercy Hospital Saint Louis | Recruiting |
| Saint Louis, Missouri, United States, 63141 | |
| Contact: Site Public Contact 314-251-7066 | |
| Principal Investigator: Jay W. Carlson | |
| Sainte Genevieve County Memorial Hospital | Recruiting |
| Sainte Genevieve, Missouri, United States, 63670 | |
| Contact: Site Public Contact 314-996-5569 | |
| Principal Investigator: Bryan A. Faller | |
| Mercy Hospital Springfield | Recruiting |
| Springfield, Missouri, United States, 65804 | |
| Contact: Site Public Contact 417-269-4520 | |
| Principal Investigator: Jay W. Carlson | |
| CoxHealth South Hospital | Recruiting |
| Springfield, Missouri, United States, 65807 | |
| Contact: Site Public Contact 417-269-4520 | |
| Principal Investigator: Jay W. Carlson | |
| Missouri Baptist Sullivan Hospital | Recruiting |
| Sullivan, Missouri, United States, 63080 | |
| Contact: Site Public Contact 314-996-5569 | |
| Principal Investigator: Bryan A. Faller | |
| Missouri Baptist Outpatient Center-Sunset Hills | Recruiting |
| Sunset Hills, Missouri, United States, 63127 | |
| Contact: Site Public Contact 314-996-5569 | |
| Principal Investigator: Bryan A. Faller | |
| Mercy Hospital Washington | Recruiting |
| Washington, Missouri, United States, 63090 | |
| Contact: Site Public Contact 636-390-1600 | |
| Principal Investigator: Jay W. Carlson | |
| United States, Montana | |
| Community Hospital of Anaconda | Recruiting |
| Anaconda, Montana, United States, 59711 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Billings Clinic Cancer Center | Recruiting |
| Billings, Montana, United States, 59101 | |
| Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
| Principal Investigator: John M. Schallenkamp | |
| Bozeman Deaconess Hospital | Recruiting |
| Bozeman, Montana, United States, 59715 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Benefis Healthcare- Sletten Cancer Institute | Recruiting |
| Great Falls, Montana, United States, 59405 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Great Falls Clinic | Recruiting |
| Great Falls, Montana, United States, 59405 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Kalispell Regional Medical Center | Recruiting |
| Kalispell, Montana, United States, 59901 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Saint Patrick Hospital - Community Hospital | Recruiting |
| Missoula, Montana, United States, 59802 | |
| Contact: Site Public Contact 406-327-3118 amy.hanneman@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Community Medical Hospital | Recruiting |
| Missoula, Montana, United States, 59804 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| United States, Nebraska | |
| CHI Health Saint Francis | Recruiting |
| Grand Island, Nebraska, United States, 68803 | |
| Contact: Site Public Contact 855-313-2409 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| CHI Health Good Samaritan | Recruiting |
| Kearney, Nebraska, United States, 68847 | |
| Contact: Site Public Contact 308-865-7963 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Saint Elizabeth Regional Medical Center | Recruiting |
| Lincoln, Nebraska, United States, 68510 | |
| Contact: Site Public Contact 855-313-2409 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Alegent Health Immanuel Medical Center | Recruiting |
| Omaha, Nebraska, United States, 68122 | |
| Contact: Site Public Contact 402-717-1510 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Alegent Health Bergan Mercy Medical Center | Recruiting |
| Omaha, Nebraska, United States, 68124 | |
| Contact: Site Public Contact 402-717-1510 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Alegent Health Lakeside Hospital | Recruiting |
| Omaha, Nebraska, United States, 68130 | |
| Contact: Site Public Contact 402-717-1510 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Creighton University Medical Center | Recruiting |
| Omaha, Nebraska, United States, 68131 | |
| Contact: Site Public Contact 402-717-1510 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Midlands Community Hospital | Recruiting |
| Papillion, Nebraska, United States, 68046 | |
| Contact: Site Public Contact 402-717-1510 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| United States, New Mexico | |
| University of New Mexico Cancer Center | Recruiting |
| Albuquerque, New Mexico, United States, 87102 | |
| Contact: Site Public Contact 505-925-0366 LByatt@nmcca.org | |
| Principal Investigator: Dulcinea D. Quintana | |
| United States, New York | |
| Glens Falls Hospital | Recruiting |
| Glens Falls, New York, United States, 12801 | |
| Contact: Site Public Contact 518-926-6700 | |
| Principal Investigator: Christopher R. Mason | |
| Stony Brook University Medical Center | Recruiting |
| Stony Brook, New York, United States, 11794 | |
| Contact: Site Public Contact 800-862-2215 | |
| Principal Investigator: Theodore G. Gabig | |
| Good Samaritan Hospital Medical Center | Recruiting |
| West Islip, New York, United States, 11795 | |
| Contact: Site Public Contact 631-376-4444 | |
| Principal Investigator: Ellis G. Levine | |
| United States, North Carolina | |
| Southeastern Medical Oncology Center-Clinton | Recruiting |
| Clinton, North Carolina, United States, 28328 | |
| Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
| Principal Investigator: Samer S. Kasbari | |
| Southeastern Medical Oncology Center-Goldsboro | Recruiting |
| Goldsboro, North Carolina, United States, 27534 | |
| Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
| Principal Investigator: Samer S. Kasbari | |
| Southeastern Medical Oncology Center-Jacksonville | Recruiting |
| Jacksonville, North Carolina, United States, 28546 | |
| Contact: Site Public Contact 910-587-9084 jfields@cancersmoc.com | |
| Principal Investigator: Samer S. Kasbari | |
| Vidant Oncology-Kenansville | Recruiting |
| Kenansville, North Carolina, United States, 28349 | |
| Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
| Principal Investigator: Misbah U. Qadir | |
| Vidant Oncology-Kinston | Recruiting |
| Kinston, North Carolina, United States, 28501 | |
| Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
| Principal Investigator: Misbah U. Qadir | |
| Vidant Oncology-Richlands | Recruiting |
| Richlands, North Carolina, United States, 28574 | |
| Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
| Principal Investigator: Misbah U. Qadir | |
| United States, North Dakota | |
| Sanford Bismarck Medical Center | Recruiting |
| Bismarck, North Dakota, United States, 58501 | |
| Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
| Principal Investigator: Preston D. Steen | |
| Sanford South University Medical Center | Recruiting |
| Fargo, North Dakota, United States, 58103 | |
| Contact: Site Public Contact 701-234-6161 | |
| Principal Investigator: Preston D. Steen | |
| Southpointe-Sanford Medical Center Fargo | Recruiting |
| Fargo, North Dakota, United States, 58103 | |
| Contact: Site Public Contact 605-312-3320 | |
| Principal Investigator: Preston D. Steen | |
| Sanford Medical Center Fargo | Recruiting |
| Fargo, North Dakota, United States, 58104 | |
| Contact: Site Public Contact 800-437-4010 | |
| Principal Investigator: Preston D. Steen | |
| Sanford Broadway Medical Center | Recruiting |
| Fargo, North Dakota, United States, 58122 | |
| Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
| Principal Investigator: Preston D. Steen | |
| Sanford Roger Maris Cancer Center | Recruiting |
| Fargo, North Dakota, United States, 58122 | |
| Contact: Site Public Contact 701-234-6161 OncologyClinicalTrialsFargo@sanfordhealth.org | |
| Principal Investigator: Preston D. Steen | |
| United States, Ohio | |
| UHHS-Chagrin Highlands Medical Center | Recruiting |
| Beachwood, Ohio, United States, 44122 | |
| Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
| Principal Investigator: Leland L. Metheny | |
| Indu and Raj Soin Medical Center | Recruiting |
| Beavercreek, Ohio, United States, 45431 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Strecker Cancer Center-Belpre | Recruiting |
| Belpre, Ohio, United States, 45714 | |
| Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Saint Elizabeth Boardman Hospital | Recruiting |
| Boardman, Ohio, United States, 44512 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Dayton Physicians LLC-Miami Valley South | Recruiting |
| Centerville, Ohio, United States, 45459 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Miami Valley Hospital South | Recruiting |
| Centerville, Ohio, United States, 45459 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Geauga Hospital | Recruiting |
| Chardon, Ohio, United States, 44024 | |
| Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
| Principal Investigator: Leland L. Metheny | |
| Adena Regional Medical Center | Recruiting |
| Chillicothe, Ohio, United States, 45601 | |
| Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| University of Cincinnati Cancer Center-UC Medical Center | Recruiting |
| Cincinnati, Ohio, United States, 45219 | |
| Contact: Site Public Contact 513-584-7698 cancer@uchealth.com | |
| Principal Investigator: Bryan C. Hambley | |
| Good Samaritan Hospital - Cincinnati | Recruiting |
| Cincinnati, Ohio, United States, 45220 | |
| Contact: Site Public Contact 513-853-1300 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Oncology Hematology Care Inc-Kenwood | Recruiting |
| Cincinnati, Ohio, United States, 45236 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Bethesda North Hospital | Recruiting |
| Cincinnati, Ohio, United States, 45242 | |
| Contact: Site Public Contact 513-853-1300 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| TriHealth Cancer Institute-Westside | Recruiting |
| Cincinnati, Ohio, United States, 45247 | |
| Contact: Site Public Contact 513-853-1300 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| TriHealth Cancer Institute-Anderson | Recruiting |
| Cincinnati, Ohio, United States, 45255 | |
| Contact: Site Public Contact 513-853-1300 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Case Western Reserve University | Recruiting |
| Cleveland, Ohio, United States, 44106 | |
| Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
| Principal Investigator: Leland L. Metheny | |
| Mount Carmel East Hospital | Recruiting |
| Columbus, Ohio, United States, 43213 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Columbus Oncology and Hematology Associates Inc | Recruiting |
| Columbus, Ohio, United States, 43214 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Riverside Methodist Hospital | Recruiting |
| Columbus, Ohio, United States, 43214 | |
| Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Grant Medical Center | Recruiting |
| Columbus, Ohio, United States, 43215 | |
| Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| The Mark H Zangmeister Center | Recruiting |
| Columbus, Ohio, United States, 43219 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Mount Carmel Health Center West | Recruiting |
| Columbus, Ohio, United States, 43222 | |
| Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Doctors Hospital | Recruiting |
| Columbus, Ohio, United States, 43228 | |
| Contact: Site Public Contact 614-566-3275 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Miami Valley Hospital | Recruiting |
| Dayton, Ohio, United States, 45409 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Dayton Physician LLC-Miami Valley Hospital North | Recruiting |
| Dayton, Ohio, United States, 45415 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Miami Valley Hospital North | Recruiting |
| Dayton, Ohio, United States, 45415 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Delaware Health Center-Grady Cancer Center | Recruiting |
| Delaware, Ohio, United States, 43015 | |
| Contact: Site Public Contact 740-615-0227 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Grady Memorial Hospital | Recruiting |
| Delaware, Ohio, United States, 43015 | |
| Contact: Site Public Contact 740-615-2403 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Dublin Methodist Hospital | Recruiting |
| Dublin, Ohio, United States, 43016 | |
| Contact: Site Public Contact 800-752-9119 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Armes Family Cancer Center | Recruiting |
| Findlay, Ohio, United States, 45840 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Blanchard Valley Hospital | Recruiting |
| Findlay, Ohio, United States, 45840 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Orion Cancer Care | Recruiting |
| Findlay, Ohio, United States, 45840 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Atrium Medical Center-Middletown Regional Hospital | Recruiting |
| Franklin, Ohio, United States, 45005-1066 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Dayton Physicians LLC-Atrium | Recruiting |
| Franklin, Ohio, United States, 45005 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Central Ohio Breast and Endocrine Surgery | Recruiting |
| Gahanna, Ohio, United States, 43230 | |
| Contact: Site Public Contact 614-488-2745 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Dayton Physicians LLC-Wayne | Recruiting |
| Greenville, Ohio, United States, 45331 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Wayne Hospital | Recruiting |
| Greenville, Ohio, United States, 45331 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Mount Carmel Grove City Hospital | Recruiting |
| Grove City, Ohio, United States, 43123 | |
| Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Greater Dayton Cancer Center | Recruiting |
| Kettering, Ohio, United States, 45409 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Kettering Medical Center | Recruiting |
| Kettering, Ohio, United States, 45429 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Fairfield Medical Center | Recruiting |
| Lancaster, Ohio, United States, 43130 | |
| Contact: Site Public Contact 740-687-8863 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Saint Rita's Medical Center | Recruiting |
| Lima, Ohio, United States, 45801 | |
| Contact: Site Public Contact 419-226-9617 | |
| Principal Investigator: Timothy D. Moore | |
| OhioHealth Mansfield Hospital | Recruiting |
| Mansfield, Ohio, United States, 44903 | |
| Contact: Site Public Contact 419-526-8018 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Marietta Memorial Hospital | Recruiting |
| Marietta, Ohio, United States, 45750 | |
| Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| OhioHealth Marion General Hospital | Recruiting |
| Marion, Ohio, United States, 43302 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| UH Seidman Cancer Center at Landerbrook Health Center | Recruiting |
| Mayfield Heights, Ohio, United States, 44124 | |
| Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
| Principal Investigator: Leland L. Metheny | |
| Knox Community Hospital | Recruiting |
| Mount Vernon, Ohio, United States, 43050 | |
| Contact: Site Public Contact 740-393-9000 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Licking Memorial Hospital | Recruiting |
| Newark, Ohio, United States, 43055 | |
| Contact: Site Public Contact 740-348-4000 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Newark Radiation Oncology | Recruiting |
| Newark, Ohio, United States, 43055 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Mercy Health Perrysburg Cancer Center | Recruiting |
| Perrysburg, Ohio, United States, 43551 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Southern Ohio Medical Center | Recruiting |
| Portsmouth, Ohio, United States, 45662 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Springfield Regional Cancer Center | Recruiting |
| Springfield, Ohio, United States, 45504 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Springfield Regional Medical Center | Recruiting |
| Springfield, Ohio, United States, 45505 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Saint Vincent Mercy Medical Center | Recruiting |
| Toledo, Ohio, United States, 43608 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Mercy Health - Saint Anne Hospital | Recruiting |
| Toledo, Ohio, United States, 43623 | |
| Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| Toledo Clinic Cancer Centers-Toledo | Recruiting |
| Toledo, Ohio, United States, 43623 | |
| Contact: Site Public Contact 800-444-3561 | |
| Principal Investigator: Rex B. Mowat | |
| Dayton Physicians LLC-Upper Valley | Recruiting |
| Troy, Ohio, United States, 45373 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Upper Valley Medical Center | Recruiting |
| Troy, Ohio, United States, 45373 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| University Hospitals Sharon Health Center | Recruiting |
| Wadsworth, Ohio, United States, 44281 | |
| Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
| Principal Investigator: Leland L. Metheny | |
| Saint Joseph Warren Hospital | Recruiting |
| Warren, Ohio, United States, 44484 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| University of Cincinnati Cancer Center-West Chester | Recruiting |
| West Chester, Ohio, United States, 45069 | |
| Contact: Site Public Contact 513-584-7698 cancer@uchealth.com | |
| Principal Investigator: Bryan C. Hambley | |
| Saint Ann's Hospital | Recruiting |
| Westerville, Ohio, United States, 43081 | |
| Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| UH Seidman Cancer Center at Saint John Medical Center | Recruiting |
| Westlake, Ohio, United States, 44145 | |
| Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
| Principal Investigator: Leland L. Metheny | |
| Saint Elizabeth Youngstown Hospital | Recruiting |
| Youngstown, Ohio, United States, 44501 | |
| Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
| Principal Investigator: Howard M. Gross | |
| Genesis Healthcare System Cancer Care Center | Recruiting |
| Zanesville, Ohio, United States, 43701 | |
| Contact: Site Public Contact 740-454-5232 sheree@columbusccop.org | |
| Principal Investigator: Timothy D. Moore | |
| United States, Oklahoma | |
| Mercy Hospital Oklahoma City | Recruiting |
| Oklahoma City, Oklahoma, United States, 73120 | |
| Contact: Site Public Contact 405-752-3402 | |
| Principal Investigator: Jay W. Carlson | |
| United States, Oregon | |
| Saint Alphonsus Medical Center-Baker City | Recruiting |
| Baker City, Oregon, United States, 97814 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Saint Charles Health System | Recruiting |
| Bend, Oregon, United States, 97701 | |
| Contact: Site Public Contact 541-706-2909 nosall@stcharleshealthcare.org | |
| Principal Investigator: Alison K. Conlin | |
| Clackamas Radiation Oncology Center | Recruiting |
| Clackamas, Oregon, United States, 97015 | |
| Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Cancer Institute Clackamas Clinic | Recruiting |
| Clackamas, Oregon, United States, 97015 | |
| Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Bay Area Hospital | Recruiting |
| Coos Bay, Oregon, United States, 97420 | |
| Contact: Site Public Contact 541-269-8392 cherie.cox@bayareahospital.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Newberg Medical Center | Recruiting |
| Newberg, Oregon, United States, 97132 | |
| Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Saint Alphonsus Medical Center-Ontario | Recruiting |
| Ontario, Oregon, United States, 97914 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
| Providence Portland Medical Center | Recruiting |
| Portland, Oregon, United States, 97213 | |
| Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Saint Vincent Medical Center | Recruiting |
| Portland, Oregon, United States, 97225 | |
| Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Oregon Health and Science University | Recruiting |
| Portland, Oregon, United States, 97239 | |
| Contact: Site Public Contact 503-494-1080 trials@ohsu.edu | |
| Principal Investigator: Rebecca W. Silbermann | |
| Saint Charles Health System-Redmond | Recruiting |
| Redmond, Oregon, United States, 97756 | |
| Contact: Site Public Contact 541-706-2909 | |
| Principal Investigator: Alison K. Conlin | |
| United States, Pennsylvania | |
| Lehigh Valley Hospital-Cedar Crest | Recruiting |
| Allentown, Pennsylvania, United States, 18103 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Lehigh Valley Hospital - Muhlenberg | Recruiting |
| Bethlehem, Pennsylvania, United States, 18017 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Christiana Care Health System-Concord Health Center | Recruiting |
| Chadds Ford, Pennsylvania, United States, 19317 | |
| Contact: Site Public Contact 302-623-4450 mhayden@christianacare.org | |
| Principal Investigator: Gregory A. Masters | |
| Pocono Medical Center | Recruiting |
| East Stroudsburg, Pennsylvania, United States, 18301 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Lehigh Valley Hospital-Hazleton | Recruiting |
| Hazleton, Pennsylvania, United States, 18201 | |
| Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
| Principal Investigator: Elie G. Dib | |
| Reading Hospital | Recruiting |
| West Reading, Pennsylvania, United States, 19611 | |
| Contact: Site Public Contact 610-988-9323 | |
| Principal Investigator: Terrence P. Cescon | |
| United States, Rhode Island | |
| Smilow Cancer Hospital Care Center - Westerly | Recruiting |
| Westerly, Rhode Island, United States, 02891 | |
| Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
| Principal Investigator: Sabrina Browning | |
| United States, South Carolina | |
| Ralph H Johnson VA Medical Center | Recruiting |
| Charleston, South Carolina, United States, 29401 | |
| Contact: Site Public Contact 843-789-7020 ashley.salvo@va.gov | |
| Principal Investigator: Oleksandra Lupak | |
| Medical University of South Carolina | Recruiting |
| Charleston, South Carolina, United States, 29425 | |
| Contact: Site Public Contact 843-792-9321 hcc-clinical-trials@musc.edu | |
| Principal Investigator: Hamza Hashmi | |
| Saint Francis Hospital | Recruiting |
| Greenville, South Carolina, United States, 29601 | |
| Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
| Principal Investigator: Robert D. Siegel | |
| Saint Francis Cancer Center | Recruiting |
| Greenville, South Carolina, United States, 29607 | |
| Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
| Principal Investigator: Robert D. Siegel | |
| United States, South Dakota | |
| Avera Cancer Institute | Recruiting |
| Sioux Falls, South Dakota, United States, 57105 | |
| Contact: Site Public Contact 605-322-3095 OncRegulatory@avera.org | |
| Principal Investigator: Vinod Parameswaran | |
| United States, Texas | |
| Saint Joseph Regional Cancer Center | Recruiting |
| Bryan, Texas, United States, 77802 | |
| Contact: Site Public Contact 855-313-2409 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| United States, Utah | |
| Huntsman Cancer Institute/University of Utah | Recruiting |
| Salt Lake City, Utah, United States, 84112 | |
| Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
| Principal Investigator: Douglas W. Sborov | |
| United States, Virginia | |
| University of Virginia Cancer Center | Recruiting |
| Charlottesville, Virginia, United States, 22908 | |
| Contact: Site Public Contact 434-243-6303 uvacancertrials@hscmail.mcc.virginia.edu | |
| Principal Investigator: Laahn H. Foster | |
| Centra Lynchburg Hematology-Oncology Clinic Inc | Recruiting |
| Lynchburg, Virginia, United States, 24501 | |
| Contact: Site Public Contact 434-200-5925 Kevin.Patel@centrahealth.com | |
| Principal Investigator: Toshihisa Satta | |
| Virginia Cancer Institute | Recruiting |
| Richmond, Virginia, United States, 23230 | |
| Contact: Site Public Contact 804-287-3000 smoore@vacancer.com | |
| Principal Investigator: Toshihisa Satta | |
| Virginia Commonwealth University/Massey Cancer Center | Recruiting |
| Richmond, Virginia, United States, 23298 | |
| Contact: Site Public Contact CTOclinops@vcu.edu | |
| Principal Investigator: Toshihisa Satta | |
| United States, Washington | |
| Providence Regional Cancer System-Aberdeen | Recruiting |
| Aberdeen, Washington, United States, 98520 | |
| Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| PeaceHealth Saint Joseph Medical Center | Recruiting |
| Bellingham, Washington, United States, 98225 | |
| Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
| Principal Investigator: Alison K. Conlin | |
| Harrison HealthPartners Hematology and Oncology-Bremerton | Recruiting |
| Bremerton, Washington, United States, 98310 | |
| Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
| Principal Investigator: Richard L. Deming | |
| Harrison Medical Center | Recruiting |
| Bremerton, Washington, United States, 98310 | |
| Contact: Site Public Contact 253-426-6882 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Highline Medical Center-Main Campus | Recruiting |
| Burien, Washington, United States, 98166 | |
| Contact: Site Public Contact 253-426-6882 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Providence Regional Cancer System-Centralia | Recruiting |
| Centralia, Washington, United States, 98531 | |
| Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Swedish Cancer Institute-Edmonds | Recruiting |
| Edmonds, Washington, United States, 98026 | |
| Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
| Principal Investigator: Alison K. Conlin | |
| Saint Elizabeth Hospital | Recruiting |
| Enumclaw, Washington, United States, 98022 | |
| Contact: Site Public Contact 253-426-6882 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Providence Regional Cancer Partnership | Recruiting |
| Everett, Washington, United States, 98201 | |
| Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Saint Francis Hospital | Recruiting |
| Federal Way, Washington, United States, 98003 | |
| Contact: Site Public Contact 253-426-6882 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Swedish Cancer Institute-Issaquah | Recruiting |
| Issaquah, Washington, United States, 98029 | |
| Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
| Principal Investigator: Alison K. Conlin | |
| Kadlec Clinic Hematology and Oncology | Recruiting |
| Kennewick, Washington, United States, 99336 | |
| Contact: Site Public Contact 509-783-4637 research@kadlecmed.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Regional Cancer System-Lacey | Recruiting |
| Lacey, Washington, United States, 98503 | |
| Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Saint Clare Hospital | Recruiting |
| Lakewood, Washington, United States, 98499 | |
| Contact: Site Public Contact 253-426-6882 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| PeaceHealth Saint John Medical Center | Recruiting |
| Longview, Washington, United States, 98632 | |
| Contact: Site Public Contact 360-514-2016 kmakin-bond@peacehealth.org | |
| Principal Investigator: Alison K. Conlin | |
| Harrison HealthPartners Hematology and Oncology-Poulsbo | Suspended |
| Poulsbo, Washington, United States, 98370 | |
| Pacific Gynecology Specialists | Suspended |
| Seattle, Washington, United States, 98104 | |
| Swedish Medical Center-Ballard Campus | Recruiting |
| Seattle, Washington, United States, 98107 | |
| Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
| Principal Investigator: Alison K. Conlin | |
| Swedish Medical Center-First Hill | Recruiting |
| Seattle, Washington, United States, 98122-4307 | |
| Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
| Principal Investigator: Alison K. Conlin | |
| Swedish Medical Center-Cherry Hill | Recruiting |
| Seattle, Washington, United States, 98122-5711 | |
| Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
| Principal Investigator: Alison K. Conlin | |
| PeaceHealth United General Medical Center | Recruiting |
| Sedro-Woolley, Washington, United States, 98284 | |
| Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Regional Cancer System-Shelton | Recruiting |
| Shelton, Washington, United States, 98584 | |
| Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Franciscan Research Center-Northwest Medical Plaza | Recruiting |
| Tacoma, Washington, United States, 98405 | |
| Contact: Site Public Contact 253-426-6882 ResearchInstituteInquiries@CommonSpirit.org | |
| Principal Investigator: Richard L. Deming | |
| Northwest Medical Specialties PLLC | Suspended |
| Tacoma, Washington, United States, 98405 | |
| PeaceHealth Southwest Medical Center | Recruiting |
| Vancouver, Washington, United States, 98664 | |
| Contact: Site Public Contact 360-514-3940 kmakin-bond@peacehealth.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Saint Mary Regional Cancer Center | Recruiting |
| Walla Walla, Washington, United States, 99362 | |
| Contact: Site Public Contact 509-897-5993 Cheryl.Dodd@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| Providence Regional Cancer System-Yelm | Recruiting |
| Yelm, Washington, United States, 98597 | |
| Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
| Principal Investigator: Alison K. Conlin | |
| United States, Wisconsin | |
| ThedaCare Regional Cancer Center | Recruiting |
| Appleton, Wisconsin, United States, 54911 | |
| Contact: Site Public Contact 920-364-3605 ResearchDept@thedacare.org | |
| Principal Investigator: Natasha C. Edwin | |
| SSM Health Dean Medical Group - Baraboo | Recruiting |
| Baraboo, Wisconsin, United States, 53913 | |
| Contact: Site Public Contact 608-355-2033 | |
| Principal Investigator: Lisa M. Lepeak | |
| Aurora Cancer Care-Southern Lakes VLCC | Recruiting |
| Burlington, Wisconsin, United States, 53105 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Marshfield Clinic-Chippewa Center | Recruiting |
| Chippewa Falls, Wisconsin, United States, 54729 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| Aurora Saint Luke's South Shore | Recruiting |
| Cudahy, Wisconsin, United States, 53110 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Marshfield Medical Center-EC Cancer Center | Recruiting |
| Eau Claire, Wisconsin, United States, 54701 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| Aurora Health Care Germantown Health Center | Recruiting |
| Germantown, Wisconsin, United States, 53022 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Aurora Cancer Care-Grafton | Recruiting |
| Grafton, Wisconsin, United States, 53024 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Aurora BayCare Medical Center | Recruiting |
| Green Bay, Wisconsin, United States, 54311 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Aurora Cancer Care-Kenosha South | Recruiting |
| Kenosha, Wisconsin, United States, 53142 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Gundersen Lutheran Medical Center | Recruiting |
| La Crosse, Wisconsin, United States, 54601 | |
| Contact: Site Public Contact 608-775-2385 cancerctr@gundersenhealth.org | |
| Principal Investigator: Kurt Oettel | |
| Mayo Clinic Health System-Franciscan Healthcare | Recruiting |
| La Crosse, Wisconsin, United States, 54601 | |
| Contact: Site Public Contact 855-776-0015 | |
| Principal Investigator: Shaji K. Kumar | |
| Marshfield Clinic - Ladysmith Center | Recruiting |
| Ladysmith, Wisconsin, United States, 54848 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| William S Middleton VA Medical Center | Recruiting |
| Madison, Wisconsin, United States, 53705 | |
| Contact: Site Public Contact 608-256-1901 ext 17007 | |
| Principal Investigator: Christopher D. Fletcher | |
| Dean Hematology and Oncology Clinic | Recruiting |
| Madison, Wisconsin, United States, 53717 | |
| Contact: Site Public Contact 608-410-2700 | |
| Principal Investigator: Lisa M. Lepeak | |
| University of Wisconsin Hospital and Clinics | Recruiting |
| Madison, Wisconsin, United States, 53792 | |
| Contact: Site Public Contact 800-622-8922 | |
| Principal Investigator: Timothy M. Schmidt | |
| Aurora Bay Area Medical Group-Marinette | Recruiting |
| Marinette, Wisconsin, United States, 54143 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Marshfield Medical Center-Marshfield | Recruiting |
| Marshfield, Wisconsin, United States, 54449 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| Aurora Cancer Care-Milwaukee | Recruiting |
| Milwaukee, Wisconsin, United States, 53209 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Aurora Saint Luke's Medical Center | Recruiting |
| Milwaukee, Wisconsin, United States, 53215 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Aurora Sinai Medical Center | Recruiting |
| Milwaukee, Wisconsin, United States, 53233 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Marshfield Clinic-Minocqua Center | Recruiting |
| Minocqua, Wisconsin, United States, 54548 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| ProHealth D N Greenwald Center | Recruiting |
| Mukwonago, Wisconsin, United States, 53149 | |
| Contact: Site Public Contact research.institute@phci.org | |
| Principal Investigator: Timothy R. Wassenaar | |
| Cancer Center of Western Wisconsin | Recruiting |
| New Richmond, Wisconsin, United States, 54017 | |
| Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
| Principal Investigator: David M. King | |
| ProHealth Oconomowoc Memorial Hospital | Recruiting |
| Oconomowoc, Wisconsin, United States, 53066 | |
| Contact: Site Public Contact 262-928-7878 | |
| Principal Investigator: Timothy R. Wassenaar | |
| Vince Lombardi Cancer Clinic - Oshkosh | Recruiting |
| Oshkosh, Wisconsin, United States, 54904 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Aurora Cancer Care-Racine | Recruiting |
| Racine, Wisconsin, United States, 53406 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Marshfield Medical Center-Rice Lake | Recruiting |
| Rice Lake, Wisconsin, United States, 54868 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| Vince Lombardi Cancer Clinic-Sheboygan | Recruiting |
| Sheboygan, Wisconsin, United States, 53081 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Marshfield Clinic Stevens Point Center | Recruiting |
| Stevens Point, Wisconsin, United States, 54482 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| Aurora Medical Center in Summit | Recruiting |
| Summit, Wisconsin, United States, 53066 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Vince Lombardi Cancer Clinic-Two Rivers | Recruiting |
| Two Rivers, Wisconsin, United States, 54241 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| ProHealth Waukesha Memorial Hospital | Recruiting |
| Waukesha, Wisconsin, United States, 53188 | |
| Contact: Site Public Contact 262-928-7632 | |
| Principal Investigator: Timothy R. Wassenaar | |
| UW Cancer Center at ProHealth Care | Recruiting |
| Waukesha, Wisconsin, United States, 53188 | |
| Contact: Site Public Contact 262-928-5539 Chanda.miller@phci.org | |
| Principal Investigator: Timothy R. Wassenaar | |
| Marshfield Clinic-Wausau Center | Recruiting |
| Wausau, Wisconsin, United States, 54401 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| Aurora Cancer Care-Milwaukee West | Recruiting |
| Wauwatosa, Wisconsin, United States, 53226 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Aurora West Allis Medical Center | Recruiting |
| West Allis, Wisconsin, United States, 53227 | |
| Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
| Principal Investigator: Michael A. Thompson | |
| Marshfield Medical Center - Weston | Recruiting |
| Weston, Wisconsin, United States, 54476 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| Marshfield Clinic - Wisconsin Rapids Center | Recruiting |
| Wisconsin Rapids, Wisconsin, United States, 54494 | |
| Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
| Principal Investigator: Ali W. Bseiso | |
| United States, Wyoming | |
| Billings Clinic-Cody | Recruiting |
| Cody, Wyoming, United States, 82414 | |
| Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
| Principal Investigator: John M. Schallenkamp | |
| Welch Cancer Center | Recruiting |
| Sheridan, Wyoming, United States, 82801 | |
| Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
| Principal Investigator: John M. Schallenkamp | |
Sponsors and Collaborators
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)
Investigators
| Principal Investigator: | Shaji K Kumar | ECOG-ACRIN Cancer Research Group |
| Responsible Party: | ECOG-ACRIN Cancer Research Group |
| ClinicalTrials.gov Identifier: | NCT04566328 |
| Other Study ID Numbers: |
EAA181 NCI-2020-06647 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) ) EAA181 ( Other Identifier: ECOG-ACRIN Cancer Research Group ) EAA181 ( Other Identifier: CTEP ) U10CA180820 ( U.S. NIH Grant/Contract ) |
| First Posted: | September 28, 2020 Key Record Dates |
| Last Update Posted: | June 23, 2023 |
| Last Verified: | June 2023 |
| Studies a U.S. FDA-regulated Drug Product: | Yes |
| Studies a U.S. FDA-regulated Device Product: | No |
Additional relevant MeSH terms:
|
Multiple Myeloma Neoplasms, Plasma Cell Neoplasms by Histologic Type Neoplasms Hemostatic Disorders Vascular Diseases Cardiovascular Diseases Paraproteinemias Blood Protein Disorders Hematologic Diseases Hemorrhagic Disorders Lymphoproliferative Disorders Immunoproliferative Disorders Immune System Diseases Dexamethasone |
Dexamethasone acetate Lenalidomide Bortezomib Daratumumab Ichthammol BB 1101 Antibodies, Monoclonal Anti-Inflammatory Agents Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Gastrointestinal Agents Glucocorticoids Hormones |